NCALA header

FW: NC DHHS Weekly Update for LTC Providers

This message is being sent on behalf of the NCDHHS Division of Public Health.


COVID-19 Vaccine Update

If your facility did not enroll in the CDC Long Term Care Pharmacy Partnership with CVS and Walgreens, we have asked your local health department to reach out to you to coordinate on vaccine services for your facilities’ staff and residents.  Please coordinate with them to make arrangements to offer vaccine services to your residents and staff.  These arrangements could include vaccination through your health department or another enrolled provider; or working with a long-term care pharmacy that has enrolled as a COVID-19 vaccine provider.  The federal government has already paid for several hundred million doses of multiple COVID-19 vaccines through Operation Warp Speed, so the vaccine will be provided at no cost to your residents and staff.  Providers may not bill for COVID-19 vaccine doses provided by the federal government, only for vaccine administration with no out-of-pocket for anyone, regardless of insurance status. The cost of vaccine will be covered by insurance or the federal government. 

Long Term Care PSAs

We want to thank you for keeping so many North Carolinians safe during the COVID-19 pandemic. Your essential work has saved countless lives and we appreciate everything you do.  As we continue to distribute and vaccinate people all across the state we wanted to share an initial PSA produced specifically for long-term care workers and residents.  The PSAs are 30, 60 and 90 seconds and can be viewed on our YouTube channel. The YouTube links can also be directly embedded into your websites, email list serves and digital marketing materials.  We’ve also made the videos available for download for you to upload to your own digital channels and display at your facilities.  Here are the links for viewing/embedding and downloading our first round of PSAs:




Thank you again for all that you do in our state and please reach out at if you have any questions about how best to use the videos.

Monoclonal Antibodies for Treatment of COVID-19

The Food and Drug Administration (FDA) has recently given emergency use authorization to two monoclonal antibody drugs for the treatment of mild to moderate COVID-19 in adults and pediatric patients with positive test results of direct SARS-CoV-2 viral testing who are 12 years of age and older weighing at least 40 kg, and who are at high risk of progressing to severe COVID-19 and/or hospitalization.  These two products, bamlanivimab (manufactured by Eli Lilly) and casirivimab/imdevimab (manufactured by Regeneron), are administered via one-time IV infusion, followed by 1-hour of direct patient observation and are intended to be given in an outpatient setting.  Currently US Department of Health and Human Services, Office of the Assistant Secretary for Preparedness and Response (ASPR) controls the fair and equitable allocation of these products to State Departments of Health on a weekly basis.  Skilled nursing facilities interested in obtaining access to these medications should reach out to their pharmacy provider.  At this time, long term care pharmacies are eligible to receive bamlanivimab after completing a brief enrollment process.  Casirivimab/imdevimab is currently only available to hospitals and hospital affiliated locations as per HHS/ASPR guidelines.  For more information regarding access to monoclonal antibodies for the treatment of COVID-19 in North Carolina, please contact Tim Davis (

CDC Long Term Care Toolkit

CDC has released a toolkit as a resource for explaining COVID-19 vaccination to both residents and staff in LTCFs. It includes resources for talking with staff, residents, and families, FAQs on the vaccines, and tips on how to prepare staff and vaccine safety monitoring and reporting.   Access it here:

Medicaid Special Bullet on Nursing Home Testing

Please see the Medicaid Special Bulletin #146 that provides process updates for nursing home staff testing activity covered by CARES Act “original funding” under Secretarial Orders 2 & 4 and announces funding now available to support testing activity occurring after December 30, 2020 (“Extension Funding”).

Please also note NC Medicaid will host a webinar on Thursday, Jan. 7, 2021, from 12 p.m. to 1 p.m. to field questions about this bulletin. To join, please use the information provided below:


North Carolina Assisted Living Association


Visit NCALA on Facebook Visit NCALA on LinkedIn

Share this email
Manage your preferences | Opt out using TrueRemove®
Got this as a forward? Sign up to receive our future emails.
View this email online.
This email was sent to .
Continue receiving our emails, add us to your address book.
Subscribe to our email list.